TY - JOUR
T1 - The methods and advances of adaptive immune receptors repertoire sequencing
AU - Liu, Hongmei
AU - Pan, Wenjing
AU - Tang, Congli
AU - Tang, Yujie
AU - Wu, Haijing
AU - Yoshimura, Akihiko
AU - Deng, Yan
AU - He, Nongyue
AU - Li, Song
N1 - Funding Information:
This work was financially supported by the National Key R&D Program of China (No. 2021YFE0191400), the National Natural Science Foundation of China (No. 61971187, 61871180), Hunan Provincial Natural Science Foundation of China (No. 2019JJ50122), and Education Department Outstanding Young Project of Hunan Province (No. 18B299).
Publisher Copyright:
© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License
PY - 2021
Y1 - 2021
N2 - The adaptive immune response is a powerful tool, capable of recognizing, binding to, and neutralizing a vast number of internal and external threats via T or B lymphatic receptors with widespread sets of antigen specificities. The emergence of high-throughput sequencing technology and bioinformatics provides opportunities for research in the fields of life sciences and medicine. The analysis and annotation for immune repertoire data can reveal biologically meaningful information, including immune prediction, target antigens, and effective evaluation. Continuous improvements of the immunological repertoire sequencing methods and analysis tools will help to minimize the experimental and calculation errors and realize the immunological information to meet the clinical requirements. That said, the clinical application of adaptive immune repertoire sequencing requires appropriate experimental methods and standard analytical tools. At the population cell level, we can acquire the overview of cell groups, but the information about a single cell is not obtained accurately. The information that is ignored may be crucial for understanding the heterogeneity of each cell, gene expression and drug response. The combination of high-throughput sequencing and single-cell technology allows us to obtain single-cell information with low-cost and high-throughput. In this review, we summarized the current methods and progress in this area.
AB - The adaptive immune response is a powerful tool, capable of recognizing, binding to, and neutralizing a vast number of internal and external threats via T or B lymphatic receptors with widespread sets of antigen specificities. The emergence of high-throughput sequencing technology and bioinformatics provides opportunities for research in the fields of life sciences and medicine. The analysis and annotation for immune repertoire data can reveal biologically meaningful information, including immune prediction, target antigens, and effective evaluation. Continuous improvements of the immunological repertoire sequencing methods and analysis tools will help to minimize the experimental and calculation errors and realize the immunological information to meet the clinical requirements. That said, the clinical application of adaptive immune repertoire sequencing requires appropriate experimental methods and standard analytical tools. At the population cell level, we can acquire the overview of cell groups, but the information about a single cell is not obtained accurately. The information that is ignored may be crucial for understanding the heterogeneity of each cell, gene expression and drug response. The combination of high-throughput sequencing and single-cell technology allows us to obtain single-cell information with low-cost and high-throughput. In this review, we summarized the current methods and progress in this area.
KW - Adaptive immune repertoire sequencing
KW - Bioinformatics
KW - High-throughput sequencing
KW - T or B cell receptors
UR - http://www.scopus.com/inward/record.url?scp=85114803008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114803008&partnerID=8YFLogxK
U2 - 10.7150/thno.61390
DO - 10.7150/thno.61390
M3 - Article
C2 - 34522220
AN - SCOPUS:85114803008
SN - 1838-7640
VL - 11
SP - 8945
EP - 8963
JO - Theranostics
JF - Theranostics
IS - 18
ER -